Holubovska, Olga, Pavlo Babich, Alla Mironenko, Jens Milde, Yuriy Lebed, Holger Stammer, Lutz Mueller, Aartjan J W Te Velthuis, Victor Margitich, and Andrew Goy. (2024) 2024. “RNA Polymerase Inhibitor Enisamium for Treatment of Moderate COVID-19 Patients: A Randomized, Placebo-Controlled, Multicenter, Double-Blind Phase 3 Clinical Trial.”. Advances in Respiratory Medicine 92 (3): 202-17. doi:10.3390/arm92030021.

Elli, Stefano, Denisa Bojkova, Marco Bechtel, Thomas Vial, David Boltz, Miguel Muzzio, Xinjian Peng, et al. (2021) 2021. “Enisamium Inhibits SARS-CoV-2 RNA Synthesis”. Biomedicines 9 (9). doi:10.3390/biomedicines9091254.

Te Velthuis, Aartjan, Tatiana Zubkova, Megan Shaw, Andrew Mehle, David Boltz, Norbert Gmeinwieser, Holger Stammer, Jens Milde, Lutz Müller, and Victor Margitich. (2021) 2021. “Enisamium Reduces Influenza Virus Shedding and Improves Patient Recovery by Inhibiting Viral RNA Polymerase Activity”. Antimicrob Agents Chemother. doi:10.1128/AAC.02605-20.

Walker, Alexander, Haitian Fan, Jeremy Keown, Victor Margitich, Jonathan Grimes, Ervin Fodor, and Aartjan Te Velthuis. (2020) 2020. “Enisamium Is a Small Molecule Inhibitor of the Influenza A Virus and SARS-CoV-2 RNA Polymerases”. BioRxiv. doi:10.1101/2020.04.21.053017.

Holubovska, Olha, Denisa Bojkova, Stefano Elli, Marco Bechtel, David Boltz, Miguel Muzzio, Xinjian Peng, et al. (2021) 2021. “Enisamium Is an Inhibitor of the SARS-CoV-2 RNA Polymerase and Shows Improvement of Recovery in COVID-19 Patients in an Interim Analysis of a Clinical Trial”. MedRxiv. doi:10.1101/2021.01.05.21249237.